Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers.

Gyu-Seong Jeong In Seob Lee Young Soo Park Beom-Su Kim Moon-Won Yoo Jeong Hwan Yook Byung-Sik Kim

Published in: Journal of gastric cancer (2020)

The ypTNM staging is a significant prognostic factor in patients who underwent CVS for localized unresectable or stage IV gastric cancers. Patients with locally advanced but unresectable lesions or with tumors with distant nodal metastasis may be good candidates for CVS.

Keyphrases

locally advanced
prognostic factors
neoadjuvant chemotherapy
lymph node
rectal cancer
squamous cell carcinoma
radiation therapy
phase ii study
liver metastases
end stage renal disease
newly diagnosed
ejection fraction
open label
study protocol
double blind